*The population prevalence of AS is estimated at 1:12,000-1:24,000 [Mertz et al 2013].
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow [Godler et al 2022].
Data collected on the parent registration page is used to further Angelman research and understanding of global prevalence rates via initiatives such as Search and Rescue. Data is collected and housed in the Global Angelman Syndrome Registry (www.angelmanregistry.info). If you are a participant in the Global Angelman Syndrome Registry, you do not need to complete this form again.
Submission of this form is considered your consent. No identifying data (name, date of or address) is provided to the project or anyone outside of the Global Angelman Syndrome Registry project without your consent.
*The population prevalence of AS is estimated at 1:12,000-1:24,000 [Mertz et al 2013].
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow [Godler et al 2022].